Skip to content

Baxter International BAX Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
Medtronic logo
MedtronicMDT
STERIS logo
STERISSTE
Solventum logo
SolventumSOLV
Abbott logo
AbbottABT

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's common stock, shares authorized (in shares)?
Baxter International (BAX) reported common stock, shares authorized (in shares) of $2B in Q1 2026.
How has Baxter International's common stock, shares authorized (in shares) changed year-over-year?
Baxter International's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $2B to $2B.
What is the long-term trend for Baxter International's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Baxter International's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $2B to $2B.